Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Clover Health Investments Corp (CLOV)

Clover Health Investments Corp (CLOV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,312,362
  • Shares Outstanding, K 516,678
  • Annual Sales, $ 1,371 M
  • Annual Income, $ -43,010 K
  • EBIT $ -56 M
  • EBITDA $ -57 M
  • 60-Month Beta 2.12
  • Price/Sales 0.73
  • Price/Cash Flow N/A
  • Price/Book 3.98

Options Overview Details

View History
  • Implied Volatility 75.57% (-13.27%)
  • Historical Volatility 52.66%
  • IV Percentile 41%
  • IV Rank 7.94%
  • IV High 394.35% on 09/10/25
  • IV Low 48.06% on 03/25/25
  • Expected Move (DTE 2) 0.21 (7.51%)
  • Put/Call Vol Ratio 0.23
  • Today's Volume 111,050
  • Volume Avg (30-Day) 36,879
  • Put/Call OI Ratio 0.34
  • Today's Open Interest 483,546
  • Open Int (30-Day) 459,332
  • Expected Range 2.62 to 3.04

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.11
  • Number of Estimates 1
  • High Estimate -0.11
  • Low Estimate -0.11
  • Prior Year -0.04
  • Growth Rate Est. (year over year) -175.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.31 +23.59%
on 12/31/25
2.88 -0.87%
on 01/14/26
+0.15 (+5.74%)
since 12/12/25
3-Month
2.16 +32.18%
on 11/21/25
3.92 -27.17%
on 10/24/25
+0.07 (+2.33%)
since 10/14/25
52-Week
2.12 +34.67%
on 08/08/25
4.87 -41.38%
on 01/24/25
-0.88 (-23.66%)
since 01/14/25

Most Recent Stories

More News
Clover Health Announces 53% Growth in Medicare Advantage Membership During AEP, Increasing to 153,000 Members as of January 1, 2026; Expects First-Ever Full Year GAAP Net Income Profitability in 2026

Clover delivers market-leading Medicare Advantage growth, establishing a strong path to achieve its first-ever full year GAAP Net Income profitability in 2026. Disciplined, core-market growth, strong...

CLOV : 2.85 (+12.20%)
Counterpart Health 2025 Results: How Better Clinical Decisions at Scale Improve Outcomes, Quality, and Cost

SAN FRANCISCO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Counterpart Health , Inc. (“Counterpart” or the “Company”), a leading AI-powered physician-enablement platform and subsidiary of Clover Health...

CLOV : 2.85 (+12.20%)
2 Cash-Heavy Stocks Worth Investigating and 1 Facing Challenges

2 Cash-Heavy Stocks Worth Investigating and 1 Facing Challenges

INCY : 107.11 (+3.56%)
PCTY : 140.69 (-2.80%)
CLOV : 2.85 (+12.20%)
Clover Health to Participate in Upcoming J.P. Morgan 2026 Healthcare Conference

WILMINGTON, Del., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Executive...

CLOV : 2.85 (+12.20%)
1 Russell 2000 Stock to Target This Week and 2 We Ignore

1 Russell 2000 Stock to Target This Week and 2 We Ignore

RBCAA : 70.70 (+1.51%)
RUSHA : 59.13 (+0.17%)
CLOV : 2.85 (+12.20%)
1 Small-Cap Stock with Competitive Advantages and 2 Facing Headwinds

1 Small-Cap Stock with Competitive Advantages and 2 Facing Headwinds

JAMF : 13.02 (unch)
OCFC : 17.97 (+1.07%)
CLOV : 2.85 (+12.20%)
Integra LifeSciences, Evolent Health, Incyte, iRhythm, and Clover Health Stocks Trade Up, What You Need To Know

Integra LifeSciences, Evolent Health, Incyte, iRhythm, and Clover Health Stocks Trade Up, What You Need To Know

EVH : 3.94 (-1.75%)
IART : 12.30 (-0.32%)
INCY : 107.11 (+3.56%)
IRTC : 160.56 (+3.29%)
CLOV : 2.85 (+12.20%)
Clover Health, GoodRx, Moderna, UFP Technologies, and Masimo Shares Are Soaring, What You Need To Know

Clover Health, GoodRx, Moderna, UFP Technologies, and Masimo Shares Are Soaring, What You Need To Know

UFPT : 257.77 (+2.10%)
GDRX : 2.74 (-4.20%)
MASI : 136.41 (+5.07%)
MRNA : 40.36 (+1.92%)
CLOV : 2.85 (+12.20%)
Clover Health to Participate in Upcoming 2025 Citi Global Healthcare Conference

WILMINGTON, Del., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Financial...

CLOV : 2.85 (+12.20%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

Relative Strength just crossed above 50%. The market is indicating support for a bullish trend.

See More Share

Business Summary

Clover Health Investments Corp. is a healthcare technology company. It uses its proprietary technology platform to collect, structure and analyze health and behavioral data to improve medical outcomes and lower costs for patients. Clover Health Investments Corp., formerly known as Social Capital Hedosophia...

See More

Key Turning Points

3rd Resistance Point 2.78
2nd Resistance Point 2.72
1st Resistance Point 2.63
Last Price 2.85
1st Support Level 2.48
2nd Support Level 2.42
3rd Support Level 2.33

See More

52-Week High 4.87
Fibonacci 61.8% 3.82
Fibonacci 50% 3.49
Fibonacci 38.2% 3.17
Last Price 2.85
52-Week Low 2.12

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar